Paige is a cutting-edge company leveraging the power of artificial intelligence to revolutionize the diagnosis and treatment of cancer. Its innovative AI technologies are transforming the field of pathology by digitizing the pathology laboratory, thereby enhancing the accuracy and efficiency of cancer diagnoses. Paige's platform is designed to support pathologists in detecting cancer with unprecedented precision, using AI-driven insights to streamline workflows and provide actionable diagnostic information. With installations in hospitals and labs worldwide, Paige is setting a new standard in digital pathology and supports clinicians across five continents. As the first to receive FDA clearance for a clinical AI application in pathology, Paige continues to lead in AI applications for cancer diagnostics, working collaboratively with industry leaders to pioneer advancements in cancer research, diagnostics, and drug development.